REFERENCES
- Agid Y. Levodopa: Is toxicity a myth?. Neurology 2001; 57(10 Suppl 3)S46–S51, [INFOTRIEVE], [CSA]
- Barthwal M. K., Srivastava N., Shukla R., Nag D., Seth P. K., Srimal R. C., Dikshit M. Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients. Acta Neurologica Scandinavia 1999; 100(5)300–304, [CSA]
- Beal M. F. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Annals of Neurology 1998; 44(3 Suppl 1)S110–S114, [INFOTRIEVE], [CSA]
- Bredt D. S., Snyder S. H. Nitric oxide: A physiological messenger molecule. Annual Review of Biochemistry 1994; 63: 175–195, [INFOTRIEVE], [CROSSREF], [CSA]
- Calne D. B. Parkinson's disease is not one disease. Parkinsonism and Related Disorders 2000; 7(1)3–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Calne D. B., Snow B. J., Lee C. Criteria for diagnosing Parkinson's disease. Annals of Neurology 1992; 32(Suppl)S125–S127, [INFOTRIEVE], [CROSSREF], [CSA]
- Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C. D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry 1989; 52(2)381–389, [INFOTRIEVE], [CROSSREF], [CSA]
- Fahn S., Elton R. L., Members of the UPDRS Development Committee. The Unified Parkinson's disease Rating Scale. Recent developments in Parkinson's disease, S. Fahn, C. D. Marsden, D. B. Calne, M. Goldstein. Macmillan Healthcare, Florham Park, N. J. 1987; 2.: 153–163
- Gatto E. M., Riobo N. A., Carreras M. C., Schopfer F. J., Pargament G. A., Poderoso J. J. Circulating plasma factors in Parkinson's disease enhance nitric oxide release of normal human neutrophils. Journal of Neurological Sciences 1999; 165(1)66–70, [CROSSREF], [CSA]
- Gatto E. M., Riobo N. A., Carreras M. C., Chernavsky A., Rubio A., Satz M. L., Poderoso J. J. Overexpression of neutrophil nitric oxide synthase in Parkinson's disease. Nitric Oxide 2000; 4(5)534–539, [INFOTRIEVE], [CROSSREF], [CSA]
- Gerlach M., Blum-Degen D., Lan J., Riederer P. Nitric oxide in the pathogenesis of Parkinson's disease. Parkinson's disease. Advances in Neurology, G M. Stern. Lippincott Williams & Wilkins, Philadelphia 1999; 80: 239–245
- Hoehn M. M., Yahr M. D. Parkinsonism: Onset, progression and mortality. Neurology 1967; 17(5)427–442, [INFOTRIEVE], [CSA]
- Ilic T. V., Jovanovic M., Jovicic A., Tomovic M. Oxidative stress indicators are elevated in de-novo Parkinson's disease patients. Functional Neurology 1999; 14(3)141–147, [INFOTRIEVE], [CSA]
- Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders 1998; 13(Suppl 1)24–34, [INFOTRIEVE], [CSA]
- Kalra J., Rajput A. H., Mantha S. V., Chaudhary A. K., Prasad K. Oxygen free radical producing activity of neutrophils in patients with PD. Molecular and Cellular Biochemistry 1992; 112(2)181–186, [INFOTRIEVE], [CROSSREF], [CSA]
- Kuiper M. A., Visser J. J., Bergmans P. L.M., Scheltens P., Wolters E. C. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. Journal of Neurological Sciences 1994; 121(1)46–49, [CROSSREF], [CSA]
- Kurtzke J. F. Neuroepidemiology. Annals of Neurology 1984; 16(3)265–277, [INFOTRIEVE], [CROSSREF], [CSA]
- Manning P., Cookson M. R., Eggett C. J., Tolias C. M., Read S. J., Hunter A. J. Real time measurement of free radical production using specific electrochemical sensors: New insights into the consequences of O2/and NO flux. Analusis 2000; 28: 493–505, [CSA]
- Molina J. A., Jimenez-Jimenez F. J., Navarro J. A., Riuz E., Arenas J., Cabrera-Valdivia F., Vazquez A., Fernandez-Calle P., Ayuso-Perlta L., Rabasa M., Bermejo F. Plasma levels of nitrates in patients with Parkinson's disease. Journal of Neurological Sciences 1994; 127(1)87–89, [CROSSREF], [CSA]
- Molina J. A., Jimenez-Jimenez F. J., Navarro J. A., Vargas C., Gomez P., Benito-Leon J., Orti-Pareja M., Cisneros E. Cerebrospinal fluid nitrate levels in patients with Parkinson's disease. Acta Neurologica Scandenavia 1996; 93(2–3)123–126, [CSA]
- Mordvintcev P., Mulsch A., Busse R., Vanin A. Online detection of nitric oxide formation in liquid aqueous phase by electron para-magnetic resonance spectroscopy. Analytical Biochemistry 1991; 199(1)142–146, [INFOTRIEVE], [CROSSREF], [CSA]
- Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 1979; 95(2)351–358, [INFOTRIEVE], [CROSSREF], [CSA]
- Qureshi G. A., Baig S., Bednar I., Sodersten P., Forsberg G., Siden A. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport 1995; 6(12)1642–1644, [INFOTRIEVE], [CROSSREF], [CSA]
- Sanchez-Ramos J. R., Overvik E., Ames B. N. A marker of oxyradical mediated DNA (8-hydroxy-2′ deoxyguanosine) is increased in nigrostriatum of Parkinson's disease brain. Neurodegeneration 1994; 3(2)197–204, [CSA]
- Sethi S., Singh M. P., Dikshit M. Nitric oxide mediated augmentation of polymorphonuclear free radical generation following hypoxia and reoxygenation. Blood 1999; 93(1)330–340, [CSA]
- Wallerath T., Gath I., Aulitzky W. E., Pollock J. S., Kleinert H., Fostermann U. Identification of NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thrombosis Haemostasis 1997; 77(1)163–167, [CSA]
- Wennmalm A., Benthin G., Petersson A. S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. British Journal of Pharmacology 1992; 106(3)507–508, [INFOTRIEVE], [CSA]
- Yamada K., Nishiwaki K., Haltori K., Senzabi K., Nagata M., Komatsu T., Shimada Y., Nabeshima T. No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. Journal of Neural Transmission 1997; 104(8–9)825–831, [INFOTRIEVE], [CROSSREF], [CSA]
- Zecca L., Rosati M., Renella R., Gaimberti M., Ambrosini A., Farcells R. G. Nitrite and nitrate levels in cerebrospinal fluid of normal subjects. Journal of Neural Transmission 1998; 105: 627–633, [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang Y., Dawson V. L., Dawson T. M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease 2000; 7(4)240–250, [INFOTRIEVE], [CROSSREF], [CSA]